Chemapotheca, LLC
6Patents
6Active
6Granted
45Portfolio score
Filing activity: Feb 25, 2014 → Oct 9, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9278904B2 | Synthesis of chiral amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds | Chemistry; Metallurgy | 4 | Active |
| US9657041B2 | Chiral aryl or aryl-alkyl phosphoramidate dexamphetamine precursors having a regioisomeric purity >99% | Chemistry; Metallurgy | 4 | Active |
| US10087202B2 | Chiral aziridine phosphoramidate compounds | Chemistry; Metallurgy | 4 | Active |
| US9321794B2 | Synthesis of racemic amphetamine derivatives by cuprate addition reaction with aziridine phosphoramidate compounds | Chemistry; Metallurgy | 4 | Active |
| US11123310B2 | Amphetamine controlled release, prodrug, and abuse-deterrent dosage forms | Human Necessities | 3 | Active |
| US11717498B2 | Methods of treatment using amphetamine controlled release, prodrug, and abuse deterrent dosage forms | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.